跳至主要内容
临床试验/IRCT201204156710N3
IRCT201204156710N3已完成2 期

The efficacy of bromocriptine for glycemic control in poorly controlled type 2 diabetic patients

Vice chancellor for research of Tabriz University of medical sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • All type 2 diabetes patients who do not have exclusion criteria. Exclusion criteria:
  • 1- Age lower than 30 and more than 65;
  • 2- HbA1C lower than 7.5% and more than 9%;
  • 3- Patients who are not willing to participate;
  • 4- Pregnant patients and lactating patients;
  • 5- Syncope attacks;
  • 6- Severe psychosis;
  • 7- Sensitive to bromocriptine and ergot drugs.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Tabriz University of medical sciences

相似试验